Graf Akcie LMNL (Liminal BioSciences Inc.). Diskuze k akciím LMNL. Aktuální informace LMNL.

Základní informace o společnosti Liminal BioSciences Inc. (Akcie LMNL)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace
Hodnota podniku (EV)
Tržby
EBITDA
Zisk
Růst v tržbách Q/Q %
Růst v tržbách Y/Y %
P/E (Cena vůči ziskům)
Forward P/E
EV/Sales
EV/EBITDA
EV/EBIT
PEG
Price/Sales
P/FCF
Price/Book
Účetní hodnota na akcii
Hotovost na akcii
FCF vůči ceně %
Počet zaměstnanců
Tržba na zaměstnance
Profit margin %
Operating margin %
Gross margin %
EBIT margin %
EBITDA margin %
EPS - Zisk na akcii
EPS - Kvartální růst %
EPS - Očekávaný růst příští rok %
Return on assets %
Return on equity %
ROIC %
ROCE %
Dluhy/Equity
Čistý dluh/EBITDA
Current ratio
Quick Ratio
Volatilita
Beta
RSI
Cílová cena analytiků
Známka akcie (dle analytiků)
Insider ownership %
Institutional ownership %
Počet akcií
Procento shortovaných akcií %
Short ratio %
Dividenda
Procentuální dividenda %
Dividenda/Zisk %
Obchodovaná od
Země

Finanční výsledky akcie LMNL

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$3.696$36.549$30.173$12.379$19.21$20.84
Cost Of Goods Sold$2.082$29.319$7.829$5.104$6.436$6.35
Gross Profit$1.614$7.231$22.344$7.276$12.775$14.49
Research And Development Expenses$56.606$70.72$77.442$66.515$39.346$31.89
SG&A Expenses$34.125$24.327$24.254$22.128$12.978$11.69
Other Operating Income Or Expenses------
Operating Expenses$92.813$124.366$109.525$93.747$58.76$49.93
Operating Income$-89.118$-87.817$-79.352$-81.368$-39.549$-29.09
Total Non-Operating Income/Expense$-87.572$-111.165$-24.624$-6.906$-8.937$28.66
Pre-Tax Income$-176.69$-198.981$-103.976$-88.273$-48.487$-0.43
Income Taxes$-0.179$-15.445$-11.38$-4.696$-4.024$-2.76
Income After Taxes$-176.511$-183.537$-92.596$-83.577$-44.463$2.33
Other Income------
Income From Continuous Operations$-156.657$-183.537$-92.596$-83.577$-44.463$34.604
Income From Discontinued Operations$0.848-----
Net Income$-155.022$-150.725$-84.647$-76.13$-39.903$2.33
EBITDA$-81.653$-83.606$-75.822$-78.913$-37.641$-27.56
EBIT$-89.118$-87.817$-79.352$-81.368$-39.549$-29.09
Basic Shares Outstanding1611111
Shares Outstanding1611111
Basic EPS$-9.65$-208.00$-120.00$-128.38$-70.50$10.00
EPS - Earnings Per Share$-9.65$-208.00$-120.00$-128.38$-70.50$10.00
# 2020 2019 2018 2017 2016 2015
Current Ratio3.03391.14312.00652.00453.26721.1397
Long-term Debt / Capital0.28922.03020.37420.21380.13410.1856
Debt/Equity Ratio0.4085-2.02160.62120.30830.15480.2279
Gross Margin43.658219.78374.053458.772666.499669.5298
Operating Margin-2411.419-240.271-262.9861-657.2901-205.8776-139.5873
EBIT Margin-2411.419-240.271-262.9861-657.2901-205.8776-139.5873
EBITDA Margin-2209.421-228.7499-251.2872-637.4634-195.9444-132.2457
Pre-Tax Profit Margin-4781.016-544.4231-344.5941-713.0735-252.4008-2.0633
Net Profit Margin-4194.719-412.3907-280.5343-614.9768-207.715811.1804
Asset Turnover0.02970.46040.13780.06180.1140.1131
Inventory Turnover Ratio0.36683.15950.28180.49481.49652.7137
Receiveable Turnover0.36872.37195.71941.86482.907611.0265
Days Sales In Receivables989.9062153.884963.8179195.7266125.534833.1022
ROE - Return On Equity-218.971376.7396-83.689-69.4533-39.073936.5754
Return On Tangible Equity-256.361286.7979908.2625-2870.0571885.296-91.5208
ROA - Return On Assets-125.9119-231.2094-42.2851-41.7156-26.376318.7729
ROI - Return On Investment-155.6556-388.1039-52.3745-54.6074-33.835229.7848
Book Value Per Share3.0688-67.6281155.7047193.0844195.5404-
Operating Cash Flow Per Share84.156349.4249-14.9513-60.6818-21.9436-40.6677
Free Cash Flow Per Share88.10654.0175-5.8462-70.6052-17.3243-53.1396